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Introduction

34
The HIV-1 pandemic resulted from a series of successive cross-species transmissions of primate 35 lentiviruses. Simian Immunodeficiency Virus (SIV) transmission from African Old World primates to 36 chimpanzees yielded the recombinant virus SIVcpz, which ultimately crossed into humans (Sharp & 195 IFITM1, Tetherin and TRIM5alpha are the most significantly-scoring hits in the PIKAHIV screen that are 196 also highly-induced by IFN ( Figure 2E ). All have well-described anti-lentiviral functions (Goujon et al., Figure 3B ). Therefore, we infected many clonal NTC and MxB-KO cell lines in 
211
KO cells is close to 1). Therefore, MxB is a the dominant, early-acting ISG inhibiting HIV replication in 212 THP-1 cells.
213
Viral entry is a key target of potent IFN-mediated restriction, specifically by ISGs such as IFITMs, 214 a family of 5 membrane-resident antiviral genes in humans with broad antiviral effects (Shi, Schwartz, & 215 Compton, 2017) . IFITMs restrict viruses that enter cells by fusion at the plasma membrane or in the 216 endosome. We hypothesized that sensitivity to MxB restriction may be dependent on the viral envelope 217 since our previous work has shown that restriction of lentiviruses using distinct entry pathways are 218 differentially affected by ISGs (Roesch, OhAinle, & Emerman, 2018) . We found that while the IFN 219 inhibition in the MxB-KO clonal lines is significantly lower than that of control clonal lines ( Figure 3D ; p = 220 0.014 unpaired t test), there is still a large inhibition of replication of VSV-G pseudotyped HIV-1 by IFNα 221 ( Figure 3D ; 53-Fold). Thus, one or more ISGs induced by IFNα potently block VSV-G mediated entry in 222 THP-1 cells independent of MxB. To ask what factors mediate this block, we repeated the HIV-CRISPR 223 screen with VSV-G pseudotyped HIV-1 in THP-1 cells. In addition to ZAP and N4BP1, shared in common 224 with the original screen (Figure 1 ), the antiviral proteins IFITM1, IFITM2 and IFITM3 are the most 225 significantly-scoring hits ( Figure 3E ). This suggests that IFITMs are the dominant IFN-induced blocks to 
234
We were surprised to find TRIM5 and Tetherin in this screen as HIV-1 is thought to be highly-235 adapted to these human restriction factors. To assay the contribution of each of these ISGs to IFN 236 inhibition of HIV in THP-1 cells, we measured viral replication in THP-1 KO pools. Pretreating cells with 237 IFNa shows ~7-fold inhibition of infection in the control NTC cell pools ( Figure 4A ) while IFN-mediated 238 inhibition of HIV was significantly lower in MxB, TRIM5 and IFITM1 KO lines than in NTCs pools (MxB_1 239 = 2.6-fold, MxB_2 = 2.5-fold, TRIM5_1 = 3.9-fold, TRIM5_2 = 4.8-fold, IFITM1_1 = 4.7-fold, IFITM1_2 = 240 6-fold and IFITM1_3 = 4.3-fold in Figure 4B ; p<0.05). The largest rescue we observed was in the MxB 241 knockout pools ( Figure 4B ), confirming that key role of MxB in the IFN phenotype. However, TRIM5 and 242 IFITM1 also contribute to IFNα inhibition ( Figure 4B ). We find no effect of Tetherin KO on early steps of 243 HIV replication as expected given its role as a late-acting HIV restriction factor (Tetherin_1 = 6-fold, 244 Tetherin_2 = 6.4-fold in Figure 4B ) (Neil et al., 2008; Van Damme et al., 2008) .
245
We also observed a significant IFNα-mediated block to the late stages of the HIV lifecycle (after 246 translation of the viral Gag protein used to detect infection in Figure 4A Figure 4D ), there is still a 4.8-fold inhibition of virus released from MxB-249 KO clonal lines (magenta in Figure 4D ). Since Tetherin is a well-characterized late-acting restriction 250 factor and was also a hit in our PIKAHIV screen, we asked if Tetherin is responsible for the late ISG block 251 we observed. We assayed virus release from KO cell pools (NTC control, IFN Pathway genes: IFNAR1, 252 STAT1, STAT2, IRF9 and Tetherin) when IFN was added 16 hours after infection to bypass early-acting 253 ISGs. Infection with Vpu-deficient HIV-1 (HIVLAIDvpu) in IFN-treated Tetherin-KO cells shows increased 254 virus release as compared to control cells (Tetherin_1 = 20.5-fold, Tetherin_2 = 14-fold in Figure 4E 
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The HIV-CRISPR screen also identifies HIV dependency factors
262
Although we designed our screen specifically to find IFN-induced factors restricting HIV-1 in THP-263 1 cells, HIV-CRISPR screening can also identify HIV dependency factors. The sgRNA sequences of 264 genes that HIV uses for enhanced viral replication will be depleted in viral supernatants as the virus will 265 be less well able to replicate specifically in these cells ( Figure 1C ). Analysis of the negative MAGeCK 266 Gene Scores, representing genes for which sgRNAs were depleted in HIV supernatants, identifies a 267 panel of candidate host factors targeted by the PIKAHIV library that are important for HIV replication 268 ( Figure 5A ). The top hit is the HIV-1 co-receptor CXCR4 ( Figure 5A ) which is required for entry by HIV-269 1LAI (note: sgRNAs targeting the receptor, CD4, are not present in the PIKAHIV library). The next highest 270 scoring hit is Siglec-1/CD169, an HIV attachment factor that has been characterized to facilitate trans 271 infection of CD4+ T cells by DCs through binding to sialylated glycosphingolipids on the HIV particle 
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5D). Infection of these cells with wt HIV-1 shows decreased levels of infection ( Figure 5D ), Therefore,
292
SEC62 is a dependency factor for HIV replication in THP-1 cells. As SEC62 is a component of the 293 machinery that mediates translocation of transmembrane proteins into the ER membrane for targeting to 294 the cell surface, we reasoned that SEC62 knockdown may be affecting cell-surface expression of HIV Figure 5D ). Interestingly, we do not observe 300 decreased cell-surface expression of CXCR4 ( Figure 5D ), suggesting that the effect of SEC62 301 knockdown on cell surface proteins is not global but specific to certain transmembrane proteins. In 
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Similarly, a recent CRISPR knockout screen demonstrated that a pooled CRISPR approach to gene 322 knockout could identify HIV dependency factors (Park et al., 2017) . Importantly, all of these high-
323
throughput approaches, with the exception of the recent CRISPR knockout screen, still require individual 324 gene knockdowns or overexpression in individual wells. The HIV-CRISPR screening approach 325 represents a significant advance in screening for host factors that affect HIV replication in several ways,
326
including: (1) we can simultaneously screen thousands of gene targets in a single experiment, (2) we can Figure S2) . Similar to the effect of ZAP, N4BP1 (Nedd4-binding protein 1) also has a 388 modest effect on HIV replication both after IFN pretreatment and when constitutively-expressed 389 (Supplemental Figure S2 ). In our screen, the anti-lentiviral function of N4BP1 appears to be genetically 390 linked to ZAP activity as N4BP1 is no longer a hit in the ZAP-KO screen ( Supplemental Table S4 ).
391
Therefore, N4BP1 may modify or enhance ZAP-mediated antiviral activity similar to the modification of 
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MYD88, a downstream effector for TLR2 activation of transcription, is also a strong hit in our dependency 410 factor screening ( Figure 5A ) suggesting that it is the downstream signaling functions of TLR2 that are 411 important for enhancing infection. In addition to CD169 and TLR2, our identification of SEC62 as a novel
412
HIV dependency factor that correlates with CD4 receptor cell surface expression highlights the ability of 413 the HIV-CRISPR screening approach to find genes that function in pathways (such as CD4 receptor 
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In summary, we developed a novel screen that is highly sensitive to detect restriction factors for 
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For lentiviral preps, 293Ts were transfected with 667ng lentiviral plasmid, 500ng psPAX2 and 333ng 553 MD2G. For HIV-1 production, 293Ts were transfected with 1ug/well proviral DNA. One day post-554 transfection media was replaced. Two or three days post-transfection viral supernatants were clarified by 555 centrifugation (1000g) and filtered through a 20μm filter. For PIKAHIV library preps, supernatants from 40 556 x 6-well plates were combined and concentrated by ultracentrifugation. 30mL of supernatant per SW-28 557 tube were underlaid with sterile-filtered 20% sucrose (1mM EDTA, 20mM HEPES, 100mM NaCl, 20% 558 sucrose) and spun in an SW28 rotor at 23,000rpm for 1 hour at 4°C in a Beckman Coulter Optima L-90K 
574
sgRNA sequences present in the genomic DNA and viral supernatants were amplified by PCR and RT-575 PCR, respectively, using primers specific for the HIV-CRISPR construct ( Supplemental Table S5) 576 (Toledo et al., 2015) . Libraries were then barcoded/prepared for Illumina sequencing by a second round 577 of PCR ( Supplemental Table S5 ). Each amplicon was then cleaned up through double-sided SPRI
578
(Agencourt AMPure XP Beads -Beckman Coulter #A63880), quantitated with a Qubit dsDNA HS Assay Supplemental Table S4 ). 
753
A: THP-1 cell pools edited for gene targets of interest were created by transducing wild type THP-1 cells 754 with lentiCRISPRv2 sgRNA constructs (2 different sgRNAs -for STAT1, STAT2, IRF9, MxB, TRIM5 and 755 Tetherin, and 3 for IFITM1), selected for 2 weeks to allow gene knockout (see Supplemental Table 6 for 756 analysis of gene knockout efficiency) and infected with HIV-1LAI with and without IFNα pretreatment in Supplemental Table S1 . ISG Gene Targets in PIKAHIV library.
805 Supplemental Table S2 . 20bp sgRNA sequences in the PIKAHIV library.
806 Supplemental Table S3 . Log2FC analysis of sgRNA enrichment (vRNA:gDNA) for wt THP-1 cells 807 pretreated with IFNα.
808 Supplemental Table S4 . 811 Supplemental Table S5 . Oligos and primers.
IFN Differential Expression Analysis in THP-1 cells and individual and
812 Supplemental Table S6 . KO scores as determined by ICE analysis for each KO pool. The r 2 value 813 for each reflects the confidence in the predicted KO score.
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